Compound 790
Identifiers
- Canonical SMILES:
C[C@@H]1CCCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O
- IUPAC name:
(2S)-3-(1H-indol-3-yl)-2-[(2-methylcyclohexanecarbonyl)amino]propanoic acid
- InChi:
InChI=1S/C19H24N2O3/c1-12-6-2-3-7-14(12)18(22)21-17(19(23)24)10-13-11-20-16-9-5-4-8-15(13)16/h4-5,8-9,11-12,14,17,20H,2-3,6-7,10H2,1H3,(H,21,22)(H,23,24)/t12-,14-,17+/m1/s1
- InChiKey:
QFJYPNYTGSGPEJ-MRRJBJDNSA-N
External links
![]() 168318067 |
![]() 23155676 |
External search
|
|
|
|
|
Bibliography (1)
Pharmacological data
| Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|
| 1 | 0 | 0 | 0 |
Targets
| PPI family | Best activity | Diseases | MMoA |
|---|---|---|---|
| LFA / ICAM | 4.55 | immune system disease | Inhibition |
Physicochemical filters
| Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
|---|---|---|---|---|
| Compliance | ||||
| MW | 328.18 g/mol | |||
| HBA | 5 | |||
| HBD | 3 | |||
| HBA + HBD | 8 | |||
| AlogP | 3.40 | |||
| TPSA | 82.19 | |||
| RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
| Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 |
| Ta | Structure | Name | Drugbank ID |
|---|---|---|---|
| 0.8898 | Golotimod | DB05475 | |
| 0.8537 | Oglufanide | DB05779 | |
| 0.8000 | Gramicidin D | DB00027 | |
| 0.7954 | Somatoprim | DB12777 | |
| 0.7544 | N-[1H-INDOL-3-YL-ACETYL]VALINE ACID | DB07953 | |
| 0.7445 | Murepavadin | DB14777 | |
| 0.7442 | LTX-315 | DB12748 | |
| 0.7426 | 5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID | DB08493 | |
| 0.7295 | N-(indole-3-acetyl)-L-aspartic acid | DB07951 | |
| 0.7174 | BQ-123 | DB12054 | |
| 0.7111 | Ilomastat | DB02255 | |
| 0.7040 | Nerofe | DB14786 | |
| 0.7018 | N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID | DB07952 | |
| 0.6948 | Tifuvirtide | DB05413 | |
| 0.6909 | D-Tryptophan | DB03225 |




